about
Disease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan.New interleukin-23 pathway inhibitors in dermatology: ustekinumab, briakinumab, and secukinumab.Treatment goals for moderate to severe psoriasis: an Australian consensus.Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasis.Medication use and associated health care outcomes and costs for patients with psoriasis in the United States.Efficacy, tolerability and safety of switching from etanercept to infliximab for the treatment of moderate-to-severe psoriasis: A multicenter, open-label trial (TANGO).Tofacitinib (CP-690,550), an oral Janus kinase inhibitor, improves patient-reported outcomes in a phase 2b, randomized, double-blind, placebo-controlled study in patients with moderate-to-severe psoriasis.Dyadic adjustment, family coping, body image, quality of life and psychological morbidity in patients with psoriasis and their partners.Psoriasis: is it the tip of the iceberg for the quality of life of patients and their families?How does psoriasis affect quality of life? Assessing an Ingram-regimen outpatient programme and validating the WHOQOL-100.Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial.ISA247: Quality of Life Results from a Phase II, Randomized, Placebo-Controlled Study
P2860
Q36083240-426BBDD6-4E45-478B-95DF-432602A546DDQ37846678-C977ECC8-0FD3-4F79-8340-07FA91959862Q38075023-ABE4F722-3418-4A20-9ED3-F6E6A4B43C4CQ39498625-FF6581EC-C8BC-4462-AF1E-C0BB01062735Q44175157-905D170A-AFE1-4DBC-8F3E-8B3C95AEFE6CQ48065188-343629B2-E66A-4554-8D3F-1184CCD1C17FQ48322904-ACA79FD6-9607-41A1-9145-49407D4D4C1CQ48641201-E95FBC9C-F0BA-429B-A81B-72551C1D4CC8Q48708208-BEA78C6D-9E7A-43F8-9B69-42AA8ACBCE82Q50943927-ADB3CAE1-90B7-417A-904B-8F5FF3C97E7EQ51917360-A77AC323-56F8-4B42-87D4-B619896F3B9AQ58404106-EF8D2ABD-1A51-4F61-9DCE-C58ECDF67BB4
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Quality-of-life issues in psoriasis.
@ast
Quality-of-life issues in psoriasis.
@en
type
label
Quality-of-life issues in psoriasis.
@ast
Quality-of-life issues in psoriasis.
@en
prefLabel
Quality-of-life issues in psoriasis.
@ast
Quality-of-life issues in psoriasis.
@en
P2093
P1433
P1476
Quality-of-life issues in psoriasis.
@en
P2093
John Y M Koo
Rita Mukhtar
P304
389-95, viii
P356
10.1016/J.DET.2004.03.016
P577
2004-10-01T00:00:00Z